NO970784L - Fremgangsmåte for opprettholdelse av tenner og oralt ben - Google Patents

Fremgangsmåte for opprettholdelse av tenner og oralt ben

Info

Publication number
NO970784L
NO970784L NO970784A NO970784A NO970784L NO 970784 L NO970784 L NO 970784L NO 970784 A NO970784 A NO 970784A NO 970784 A NO970784 A NO 970784A NO 970784 L NO970784 L NO 970784L
Authority
NO
Norway
Prior art keywords
procedure
oral bone
maintaining teeth
teeth
maintaining
Prior art date
Application number
NO970784A
Other languages
English (en)
Other versions
NO970784D0 (no
Inventor
William Sales
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO970784D0 publication Critical patent/NO970784D0/no
Publication of NO970784L publication Critical patent/NO970784L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Fremgangsmåte for opprettholdelse av tenner og oralt ben, omfattende administrering til et menneske som trenger dette, en effektiv mengde av en forbindelse med formel (1) OCHjCHj-rJ R^O' 0) hvor R^ og r3 uavhengig er hydrogen, -CH3, (a) eller (b), hvor Ar eventuelt er substituert fenyl; R^ er valgt fra gruppen omfattende pyrrolidon, heksametylenimino og piperidino; eller et farmasøytisk akseptabelt salt eller solvat derav.
NO970784A 1994-08-22 1997-02-20 Fremgangsmåte for opprettholdelse av tenner og oralt ben NO970784L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29423794A 1994-08-22 1994-08-22
PCT/US1995/010582 WO1996005829A1 (en) 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone

Publications (2)

Publication Number Publication Date
NO970784D0 NO970784D0 (no) 1997-02-20
NO970784L true NO970784L (no) 1997-02-20

Family

ID=23132491

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970784A NO970784L (no) 1994-08-22 1997-02-20 Fremgangsmåte for opprettholdelse av tenner og oralt ben

Country Status (14)

Country Link
EP (1) EP0769946A4 (no)
JP (1) JPH10504573A (no)
KR (1) KR970705386A (no)
AU (1) AU692598B2 (no)
CA (1) CA2198108A1 (no)
CZ (1) CZ52197A3 (no)
FI (1) FI970713A7 (no)
HU (1) HUT76891A (no)
IL (1) IL115017A0 (no)
MX (1) MX9701331A (no)
NO (1) NO970784L (no)
WO (1) WO1996005829A1 (no)
YU (1) YU55495A (no)
ZA (1) ZA956987B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Also Published As

Publication number Publication date
KR970705386A (ko) 1997-10-09
WO1996005829A1 (en) 1996-02-29
NO970784D0 (no) 1997-02-20
AU3408895A (en) 1996-03-14
CA2198108A1 (en) 1996-02-29
YU55495A (sh) 1998-07-10
FI970713A0 (fi) 1997-02-20
EP0769946A1 (en) 1997-05-02
MX9701331A (es) 1997-05-31
JPH10504573A (ja) 1998-05-06
ZA956987B (en) 1997-02-21
FI970713L (fi) 1997-02-20
FI970713A7 (fi) 1997-02-20
AU692598B2 (en) 1998-06-11
IL115017A0 (en) 1995-12-08
EP0769946A4 (en) 1997-11-05
CZ52197A3 (en) 1997-08-13
HUT76891A (en) 1997-12-29

Similar Documents

Publication Publication Date Title
IL111288A (en) Uses of 2-phenyl-3-aroylbenzothiophenes and 3-phenyl-4-aroyl-1,2-dihydronaphthalenes for the preparation of a medicament for inhibiting smooth muscle cell proliferation and restinosis
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
HUT71344A (en) Pharmaceutical compositions for inhibiting thrombin containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
IL111284A (en) 2-phenyl-3-aroylbenzothiophenes for use as medicaments for inhibiting endometriosis
DK0771200T3 (da) Anvendelse af raloxifen og dets analoger til fremstilling af et medikament til behandling af virale sygdomme
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
DK0659417T3 (da) Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
NO970785L (no) Fremgangsmåte for benheling og fraktur-reparasjon
NO971794L (no) Fremgangsmåte for hemming av tilstander forbundet med bradykinin
NO971029L (no) Fremgangsmåter for hemming av endometriale metoser
NO973103L (no) Fremgangsmåte for inhibering av veksthormoneffekter
DK0771201T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9701328A (es) Metodos de reduccion de la cicatrizacion en la curacion de heridas.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.